Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

EndoPod

Pregnancy & Prolactinoma - Simplified

11 Oct 2020

Description

Welcome back to EndoPod! Prolactinomas are the commonest pituitary tumours, affecting 1 in 10,000 people. In this episode, Hepsi is taking you through the details of prolactinomas and more importantly, how they affect pregnant people. What precautions do they have to take to ensure a safe pregnancy? Listen in to find out! This is the simplified version for our listeners without a scientific/medical background Voice - Hepsi Xavier (Y3) Transcript - Heo Mun Ho (Y4) Editor - Hepsi Xavier (Y3) Aberdeen University Endocrinology Society are a student lead organisation. All information provided in this podcast are intended for educational purposes. This podcast is not intended to replace the advice of a qualified health professional. The students involved in the making of this episode are in the 3rd year of their medical education. References: Almalki, M. et al. (2015). Managing Prolactinomas during Pregnancy. Frontiers in Endocrinology, 6. Barraud, S. et al. (2020). Evolution of macroprolactinomas during pregnancy: A cohort study of 85 pregnancies. Clinical Endocrinology, 92(5), pp.421-427. Grattan, D. (2015). 60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-prolactin axis. Journal of Endocrinology, 226(2), pp.T101-T122. Molitch, M. (2015). ENDOCRINOLOGY IN PREGNANCY: Management of the pregnant patient with a prolactinoma. European Journal of Endocrinology, 172(5), pp.R205-R213. Pathwaymedicine.org. n.d. Prolactin Physiology. [online] Available at: [Accessed 29 August 2020]. Pituitary.org.uk. n.d. Prolactinoma | The Pituitary Foundation. [online] Available at: [Accessed 29 August 2020].

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.